PDS selects GPC for lobbying brief

The Parkinson’s Disease Society (PDS) is gearing up to launch a raft of PA campaigns in Westminster and Brussels in an attempt to ensure controversy over last week’s opening of the first UK stem cell bank does not affect research and funding.

The PDS has appointed GPC International’s health practice to bolster its profile among MPs in the run-up to the general election. It intends to lobby parliament on the Human Tissues Bill as well as the Charities Bill, the Disability Discrimination Act and the Carers Bill. MEPs will also be targeted in regard to the European Human Tissues and Cells Directive.

‘The PDS supports the use of embryonic stem cells in research, within the existing regulatory and ethical framework, as it offers great promise for new treatments for a wide range of conditions including Parkinson’s,’ said PDS chief executive Linda Kelly.

GPC International is also expected to provide PA support on National Institute for Clinical Excellence (NICE) guideline issues, the provision of specialist training for Parkinson’s treatment nurses, and employment and palliative care concerns.

The agency already handles work for the PDS in Edinburgh and will manage its PA strategy in England on a year-long contract.

GPC International associate director and head of health practice Claire Ashbridge-Thomlinson leads the account.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in